Cardiometabolic risk in pseudohypertriglyceridemia resulting from hyperglycerolemia
Hyperglycerolemia per se is not associated with premature ASCVD. Its screening should be considered only in patients with persistent hypertriglyceridemia unresponsive to treatment. The confirmation of hyperglycerolemia can help the clinician reassure the patient concerning his CV risk, as no further assessment is required other than common CV risk factors monitoring, including body weight increase and insulin resistance that may appear over the life course.
Authors
- Jean-François Perregaux
- Boris Hansel (ORCID: https://orcid.org/0000-0002-9461-3523)
- Philippe Couvert (ORCID: https://orcid.org/0000-0002-7607-2057)
- Alain Carrié
- Antonio Gallo (ORCID: https://orcid.org/0000-0002-8887-994X)
- Randa Bittar
- Dominique Bonnefont‐Rousselot (ORCID: https://orcid.org/0000-0003-4689-9202)
- Diana Kadouch (ORCID: https://orcid.org/0000-0001-7246-0629)
- Philippe Giral
- Mathilde Varret (ORCID: https://orcid.org/0000-0001-9261-1551)
- Syrine Jaraya
- Sterenn Guillerme
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut de Médecine et d'Epidémiologie Africaines (FR)
- Hôpitaux Universitaires Paris-Ouest (FR)
- National Institute of Health (AM)
- Centre d'Immunologie et des Maladies Infectieuses (FR)
- Laboratoire de Recherche Vasculaire Translationnelle (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR)
- Carrier (United States) (US)
Publication Details
- Journal
- Journal of clinical lipidology
- Published
- 2025-08-13
- DOI
- https://doi.org/10.1016/j.jacl.2025.08.007
- Primary Topic
- Lipid metabolism and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00